Michael J. LaBarre
CIK 1507174 · SVP, CHIEF TECHNICAL OFFICER · last filed 2025-02-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
65
Lifetime Open-Market Net
-$25.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, CHIEF TECHNICAL OFFICER | 173,856 | — | — | -$25.16M | 65 | 2025-02-27 |
Recent Filings · Page 4 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-28 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −10,000 | -$495.5K | EDGAR |
| 2023-02-21 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +3,234 | -$141.8K | EDGAR |
| 2023-02-17 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | −7,784 | -$541.5K | EDGAR |
| 2023-02-14 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +10,340 | -$277.7K | EDGAR |
| 2023-01-18 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −10,000 | -$504.6K | EDGAR |
| 2022-12-13 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −10,000 | -$586.7K | EDGAR |
| 2022-11-16 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −10,000 | -$541.3K | EDGAR |
| 2022-02-17 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +2,216 | -$40.3K | EDGAR |
| 2022-02-14 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +14,075 | -$264.8K | EDGAR |
| 2021-10-12 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +8,050 | $105.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.